Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endotoxin Challenge in Alcohol Use Disorder
NCT04310423Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Oct 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by University of California, Los Angeles. Primary endpoints: Cue-induced Craving and Change in Negative Mood. Started Oct 2021; status: completed.
Beyond the preview
Go deeper on NCT04310423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04310423.